James is Head of Corporate Advisory at Mercia Asset Management PLC. He collaborates with colleagues across the Group, management teams of portfolio companies, as well as co-investors and external advisors, to accelerate the funding and scaling of portfolio companies in the UK and internationally.
Prior to Mercia, James undertook scientific research at Cambridge Computational Biology Institute, University of Cambridge, before starting his career at Cambridge Consultants. He then entered venture capital and became an investment manager at NBGI Ventures, a venture capital firm in London investing in medical technology companies in Europe and the US, before its spin-out to form Stage Capital. More recently, he was an investment director at Fosun Pharma in Shanghai, China, focusing on venture capital and university IP commercialisation investment funds and spin-out companies. James holds an MPhil from the University of Cambridge and a BSc (Hons) from the University of London.